Convalescent plasma fails to reduce deaths or stop progression to severe disease ... Oct 24
Pfizer to develop ARX-1796 which, if approved, has potential to be the first novel oral beta-lactamase inhibitor + antibiotic combination in more than 35 ... Oct 24
The Bharat Biotech, which is into developing Covaxin - a vaccine candidate for COVID-19, on Friday said that it will now be conducting Phase III ... Oct 24
-Advertisements-